Skip to content

Author

Keisuke Morita

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

CRISPR-Mediated Epigenetic Reprogramming Attenuates Inflammatory Cell Injury Through Targeted Transcriptional Modulation: An Experimental in Vitro and in Vivo Study

The concordant in vitro and in vivo findings identify targeted epigenetic reprogramming as a potential strategy for controlling pathological inflammation without permanent alteration of genomic DNA.

Hiroshi Takamura, Yuki Nakamura, Rina Fujimoto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.